Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson Nov 08, 2019 2:02pm
105 Views
Post# 30328705

RE:RE:Nasdaq?

RE:RE:Nasdaq?
BlueChip9 wrote: One post or two talk about $0,50 for the reverse split of 6:1 for the Nas. But, it would take more than that because it's $3 US. So it's more like $0,66 - $0,72.... Very far of $0,07.

It will not take much to jump to those prices (0.50-0.75) once the company demonstrates that it has generated revnue and is executing. Nearly every post on here has been a bash lately. Several "know-it-all's" on here seem to know the results from Q3. A lot of bashing for the sake of bashing. The reality is, nobody knows for certain whether the revenues and test counts have increased. It is absolutely hillarious that individuals have to reiterate the facts here to dispell morons posting BS. The reality is, the company has a signed deal in Europe, this will generate millions of extra $$. The company has opened online purchasing of tests, again, allowing accessibility and will generate more revenue. Why are we all hung up on things that don't matter right now?? This board is beyond toxic and it is frustraing to see the BS. I am aware it won't stop and people have agendas, but for those who may be influenced: don't get caught up on the hype. There are several posters on this board who have completed incredible DD and have facts to back up their comments, thank you for that. For all of those lame bashing, not providing anything to backup their running mouths, it's getting old. 
Bullboard Posts